Advanced search
Publication Cover
Therapeutics and Clinical Risk Management Volume 3, 2007 - Issue 5
Submit an article Journal homepage
68
Views
2
CrossRef citations to date
0
Altmetric
Review

Once-daily MMX mesalamine for the treatment of mild-to-moderate ulcerative colitis

Prashant Kedia1 Pritzker Medical School, The University of ChicagoChicago, IL, USA
&
Russell D Cohen2 Clinical Inflammatory Bowel Disease, Department of Medicine, Section of Gastroenterology, The University of Chicago Medical CenterChicago, IL, USACorrespondence[email protected]
Pages 919-927 | Published online: 24 Dec 2022

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.